April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Comparing Conventional and Wavefront-Optimized LASIK for the Treatment of Hyperopia
Author Affiliations & Notes
  • G. O. Waring, IV
    Ophthalmology, Private Practice, Atlanta, Georgia
  • D. S. Durrie
    Ophthalmology, Durrie Vision, Overland Park, Kansas
    Ophthalmology, University of Kansas Medical Center, Prarie Village, Kansas
  • R. T. Smith
    Ophthalmology, Durrie Vision, Overland Park, Kansas
  • J. E. Stahl
    Ophthalmology, Durrie Vision, Overland Park, Kansas
    Ophthalmology, University of Kansas Medical Center, Prarie Village, Kansas
  • Footnotes
    Commercial Relationships  G.O. Waring, IV, Alcon, R; D.S. Durrie, Alcon, C; R.T. Smith, None; J.E. Stahl, Alcon, C.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 581. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G. O. Waring, IV, D. S. Durrie, R. T. Smith, J. E. Stahl; Comparing Conventional and Wavefront-Optimized LASIK for the Treatment of Hyperopia. Invest. Ophthalmol. Vis. Sci. 2009;50(13):581.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare the differences in subjective and objective visual outcomes after conventional and wavefront-optimized (WFO) laser in situ keratomileusis (LASIK) for the treatment of hyperopia.

Methods: : In a prospective, randomized, single-center clinical trial, fifty-one consecutive eyes underwent LASIK for the treatment of hyperopia. Patients were divided evenly between groups treated with conventional Alcon LADAR4000 and wavefront-optimized Allegretto Wavelight. The refractive and visual outcomes, induced spherical aberrations, and contrast sensitivity were analyzed.

Results: : Postoperative day one, 20% of eyes treated with a conventional profile had UCDVA of 20/20 vision or better compared to 65% of eyes receiving WFO treatment (p=0.0011). By six months, UCDVA was 20/20 or better in 72% and 84% of the conventional and WFO groups respectively (p=0.31). Six month mean MRSE was -0.21 ± 0.47D and -0.16 ± 0.27D for the conventional and WFO groups respectively (p=0.65). Induced spherical aberration was -0.54 ± 0.32µ and -0.42 ± 0.21µ for the conventional and WFO groups respectively (p=0.1195). The respective change in mesopic and photopic area under the log contrast sensitivity function was -0.05 ± 0.29 and -0.05 ± 0.23 for the conventional group and 0.08 ± 0.39 and 0.08 ± 0.41 for WFO (p=0.1970). No patients lost more than one line of BCVA.

Conclusions: : Both WFO and conventional ablation profiles predictably and safely correct low to moderate hyperopia. WFO showed superior results with regards to rapid visual recovery.

Keywords: refractive surgery: LASIK • hyperopia • refractive surgery: comparative studies 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×